drugset / Trial / NCT00189943

Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects

NCT00189943

Phase 1 Completed 90 enrolled Bavarian Nordic
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to collect information on the safety, tolerability and immunogenicity of an investigational smallpox vaccine at different doses and using different routes of administration in vaccinia-naive and vaccinated healthy volunteers

Timeline

Start
2001-04
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject IMVAMUNE Vaccine

Indications